Arrowstreet Capital, Limited Partnership Amneal Pharmaceuticals, Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $122 Billion
- Q4 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 1,541,058 shares of AMRX stock, worth $13.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,541,058
Previous 2,068,979
25.52%
Holding current value
$13.4 Million
Previous $17.2 Million
29.09%
% of portfolio
0.01%
Previous 0.01%
Shares
20 transactions
Others Institutions Holding AMRX
# of Institutions
205Shares Held
123MCall Options Held
362KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA14.8MShares$129 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$107 Million2.69% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$97.8 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$93 Million1.4% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il8.98MShares$77.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.31B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...